SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo)
DEPO 7.300+1.7%Aug 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Czechsinthemail who wrote (597)12/19/1997 2:54:00 PM
From: John McCarthy  Read Replies (2) of 887
 
Baird,

I'm staying in for two reasons.

At this point, NO ONE knows HOW WELL the product
works versus a control group.

As explained succinctly in a previous post,
the company did one kind of math, and the board
another.

The FDA will hold the line, but if I believe what
I have read previously, if the FDA said go ahead
and submit with the small group, there was some
disconnect between the Advisory board and the
FDA folks who had guided DEPO along.

Or else, DEPO's management is worse than I think.

Your previous posts have covered the issue of
side effects.

Regards,

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News